HPV Vaccination Rates Suboptimal Within Ages 9 to 12 Years
For most of the study period, higher rates of HPV vaccination initiation and up-to-date rates were seen for non-Hispanic Blacks, Hispanics
Early-Life Exposure to Antibiotics Linked to Atopic Dermatitis
Exposure in utero and during first year of life linked to increased risk for atopic dermatitis; attenuated in sibling-control analysis
FDA Plans to Approve Pfizer Vaccine for Those Aged 12 Years and Older
Pfizer's trial in adolescents showed its vaccine worked as well in teens as it does in adults
Adding Aspirin May Up Risk for Patients on DOAC for A-Fib/VTE
Among patients with a-fib and/or VTE, about one-third received ASA in addition to a DOAC with no clear indication for ASA
Many Patients Prefer Stool-Based Colorectal Cancer Screening Tests
Multitarget stool DNA test, fecal immunochemical test, or guaiac-based fecal occult blood test preferred over colonoscopy
Farxiga Approved to Reduce Risk for CKD Progression
SGLT2 inhibitor approved for patients with CKD to prevent kidney function decline, kidney failure, CV death, hospitalization for heart failure
FDA Approves Higher-Dose Naloxone Hydrochloride Nasal Spray
8-mg dose of naloxone hydrochloride nasal spray now approved with 2-mg and 4-mg doses
Effect of COVID-19 on Breast Cancer Treatment Examined
More patients with estrogen receptor-positive, HER2-negative breast cancer treated with neoadjuvant endocrine therapy due to COVID-19
Anxiety-Related Adverse Event Clusters ID’d After Janssen Vaccine
Rate of syncope was 8.2 per 100,000 doses after Janssen COVID-19 vaccination versus 0.05 per 100,000 after flu shots
